REGISTERED NUMBER: 04998313 (England and Wales)

Financial Statements for the Year Ended 31st December 2024

for

Esplanade Healthcare Limited

Page

Company Information

1

Chartered Accountants' Report

2

Balance Sheet

3

Notes to the Financial Statements

5

DIRECTOR:

Dr J H Redman

REGISTERED OFFICE:

1 The Gatehouse

Shorts Reach

The Esplanade

Rochester

Kent

ME1 1QP

REGISTERED NUMBER:

04998313 (England and Wales)

ACCOUNTANTS:

Beak Kemmenoe

Chartered Accountants

1-3 Manor Road

Chatham

Kent

ME4 6AE

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Esplanade Healthcare Limited for the year ended 31st December 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Esplanade Healthcare Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Esplanade Healthcare Limited and state those matters that we have agreed to state to the director of Esplanade Healthcare Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Esplanade Healthcare Limited and its director for our work or for this report.

It is your duty to ensure that Esplanade Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Esplanade Healthcare Limited. You consider that Esplanade Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Esplanade Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Beak Kemmenoe

Chartered Accountants

1-3 Manor Road

Chatham

Kent

ME4 6AE

25th September 2025

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

1,373

2,225

Investments

6

69,159

67,485

70,532

69,710

CURRENT ASSETS

Stocks

1,735

1,850

Debtors

7

402,270

699,012

Cash at bank and in hand

307,505

170,453

711,510

871,315

CREDITORS

Amounts falling due within one year

8

23,072

150,417

NET CURRENT ASSETS

688,438

720,898

TOTAL ASSETS LESS CURRENT LIABILITIES

758,970

790,608

PROVISIONS FOR LIABILITIES

555

647

NET ASSETS

758,415

789,961

CAPITAL AND RESERVES

Called up share capital

1

1

Fair value reserve

9

(16,784

)

(18,458

)

Retained earnings

775,198

808,418

SHAREHOLDERS' FUNDS

758,415

789,961

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 25th September 2025 and were signed by:

Dr J H Redman - Director

1.	STATUTORY INFORMATION

Esplanade Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2004, is being amortised evenly over its estimated useful life of ten years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1st January 2024

and 31st December 2024

150,000

AMORTISATION

At 1st January 2024

and 31st December 2024

150,000

NET BOOK VALUE

At 31st December 2024

-

At 31st December 2023

-

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1st January 2024

and 31st December 2024

25,014

DEPRECIATION

At 1st January 2024

22,789

Charge for year

852

At 31st December 2024

23,641

NET BOOK VALUE

At 31st December 2024

1,373

At 31st December 2023

2,225

6.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

At 1st January 2024

67,485

Revaluations

1,674

At 31st December 2024

69,159

NET BOOK VALUE

At 31st December 2024

69,159

At 31st December 2023

67,485

Cost or valuation at 31st December 2024 is represented by:

Other

investments

£

Valuation in 2020

(3,842

)

Valuation in 2021

(1,911

)

Valuation in 2022

(13,534

)

Valuation in 2023

(3,013

)

Valuation in 2024

1,674

Cost

89,785

69,159

If listed investments had not been revalued they would have been included at the following historical cost:

2024

2023

£

£

Cost

89,785

89,785

Listed investments were valued on on an open market basis on 31st December 2024 by Redmayne & Bentley .

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

8,445

13,180

Other debtors

393,825

685,832

402,270

699,012

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Taxation and social security

5,945

22,652

Other creditors

17,127

127,765

23,072

150,417

9.

RESERVES

Fair

value

reserve

£

At 1st January 2024

(18,458

)

Fair value movement

1,674

At 31st December 2024

(16,784

)

10.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31st December 2024 and the period ended 31st December 2023:

2024

2023

£

£

Dr J H Redman

Balance outstanding at start of year

533,658

630,842

Amounts advanced

666,066

2,816

Amounts repaid

(866,000

)

(100,000

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

333,724

533,658

11.	RELATED PARTY DISCLOSURES

At 31 December 2024 the director, Dr J H Redman, owed the company £333,724 through his directors loan account.

12.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr J H Redman.